Although we did not have single cell level data to show subsets of TAMs in cervical cancer, we showed that, by using bulk RNA-seq data of cervical cancer from TCGA, C1QC+ and SPP1+ TAMs gene signatures, but not M1 and M2 gene signatures, could divide cervical cancer patients into subgroups with different prognosis and different tumor stages. Here, SPP1 is linked to neoplasm.